U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233954) titled 'Intraoperative Use of I.V. Sodium Fluorescein in Suspected CNS Tumors' on Nov. 14.
Brief Summary: The FLUO.CER.TUM study is a prospective observational clinical trial conducted at the IRCCS Foundation Neurological Institute "Carlo Besta" in Milan, Italy. It investigates the intraoperative use of intravenous sodium fluorescein as a fluorescent tracer to assist in the surgical resection of suspected malignant tumors of the central nervous system (CNS). These tumors typically present as contrast-enhancing masses on pre-operative MRI or CT scans.
Malignant brain tumors are notoriously difficult to fully resect due to challenges in dist...